Author: Thomas Edward

[ad_1] Lawmakers in Michigan last week passed a resolution in which they called on members of the United States Congress, as well as the Department of Defense, and Department of Veterans Affairs, to “prioritize research and investment in non-technology treatment options for servicemembers and veterans who have psychological trauma as a result of military service.” The resolution spans three pages and was sponsored by more than 20 members of the Michigan legislature. It was approved in the state Senate last Thursday. The measure makes reference to the severe psychological toll endured by members of the military, noting that the “men…

Read More

[ad_1] A study on MDMA treatment for new mothers, which launched in the spring, is being led by Dr. Larry Leeman, the medical director of the University of New Mexico’s Milagro Program. Leeman “treats expectant mothers experiencing opioid use disorder,” and “was dismayed to see that many of his patients eventually resumed opioid use due untreated post-traumatic stress disorder (PTSD),” according to a press release from the university on the study. “Now, Leeman and his colleagues are launching a first-of-its-kind pilot study to see whether a regimen of trauma-focused therapy coupled with doses of MDMA – popularly known to rave…

Read More

[ad_1] For North Carolina, where both recreational and medical cannabis are both illegal under the state’s law, the outcome clears the way for the Tar Heel State’s first dispensary. The Associated Press reported that unofficial results of the vote on Thursday showed “that 70% of voters said ‘yes’…in a referendum that opens the door to the western North Carolina reservation being the first location in the state where pot for recreational use can be legally purchased.” “The question put to a vote by the Eastern Band tribal council asked whether members supported legalizing the possession and use of cannabis by…

Read More

[ad_1] Newly released data published in last month’s issue of the Journal of Addiction Medicine concluded that marijuana treatments for young people have declined following legalization. The data, presented by researchers at Temple University, “were extracted from the Treatment Episode Dataset—Admissions and used to calculate trends in the number and proportion of criminal justice referrals” for cannabis use disorder treatment. They sought to investigate “whether the proportion of referrals to cannabis use disorder (CUD) treatment from the criminal justice system declined among adolescents (aged 12–17 years) and young adults (aged 18–24 years) following state recreational (adult use) cannabis legalization in…

Read More

[ad_1] Chicago-based marijuana company Cresco Labs Inc. announced on Thursday that it will become the “first cannabis company to launch cannabis advertisements on Spotify, the world’s most popular audio streaming subscription service with more than 551 million users and 220 million subscribers.” The ad campaign will promote Sunnyside, a chain of dispensaries operated by Cresco Labs and will include “30 second audio and in-app digital banners that drive to the retailer’s proprietary e-commerce platform,” the company said in a press release. Those ads will be specifically targeted to Spotify listeners (and would-be Sunnyside customers) in Illinois, where recreational cannabis is…

Read More

[ad_1] The Japan Times reported this week on data published by the National Center of Neurology and Psychiatry, an agency under the national Ministry of Health, that illuminated how excessive “use of such over-the-counter drugs has grown more popular in recent years, with the number of cases of addiction involving them increasing sixfold between 2012 and 2020.” But the outlet also touched on a “more recent study conducted by Saitama Medical University’s Clinical Toxicology Center found that among eight surveyed medical institutions, a total of 124 patients were taken to the hospital for overdosing on over-the-counter drugs between May 2021…

Read More

[ad_1] Last month, the university’s Center for the Science of Psychedelics launched a free, online course titled “Psychedelics and the Mind.” The launch of the course marks another expansion of the Center, which itself launched three years ago. According to The Daily Californian, the course “will be taught by David Presti, neurobiology professor and one of [Berkeley Center for the Science of Psychedelics] founders.” It will be available for free due to the largess of the Steve and Alexandra Cohen Foundation.  Steve Cohen, the billionaire owner of the New York Mets, is a longtime advocate of psychedelic research and therapy.…

Read More

[ad_1] A study by American Medical Association, published late last month, sought to measure the “efficacy and safety of psilocybin in patients with major depressive disorder” and to “evaluate the magnitude, timing, and durability of antidepressant effects and safety of a single dose of psilocybin in patients with [major depressive disorder].” Researchers conducted a “a randomized, placebo-controlled, 6-week trial in 104 adults, a 25-mg dose of psilocybin administered with psychological support,” ultimately determining that the psilocybin treatment “was associated with a rapid and sustained antidepressant effect, measured as change in depressive symptom scores, compared with active placebo,” and that no…

Read More

[ad_1] Rep. Chuck Edwards, who represents a district in western North Carolina, unveiled the “Stop Pot Act” on Friday, saying that the bill “will withhold 10 percent of federal highway funds for governments that violate federal law under the Controlled Substances Act, which prohibits recreational marijuana and classifies it as a Schedule I drug.” The legislation “does not apply to jurisdictions that authorize medical use of marijuana when prescribed by a licensed medical professional,” the congressman’s office said in a press release. “The laws of any government should not infringe on the overall laws of our nation, and federal funds…

Read More

[ad_1] Dramatic new footage released by Mexico’s Navy shows officers carrying out a major drug bust after a high-speed chase at sea. The footage, which has been widely reported on in the media, depicts a pair of operations carried out by the Navy; in one, an officer can be seen descending from an overhead helicopter to arrive on a boat that was carrying a large amount of drugs. According to CTV News, “Mexican authorities say they have seized some 9,700 pounds of cocaine during two operations on Aug. 22 and 23 in the Pacific Ocean.” “Both operations resulted in high-speed…

Read More

[ad_1] A poll from YouGov “found that a significant percentage of respondents across different age groups, including 18-24 year olds (36%) and 25-49 year olds (30%), expressed interest in trialing psilocybin and other currently illegal substances like ketamine, MDMA, and DMT for treating mental health conditions,” Psychedelic Spotlight reported. The outlet noted that the YouGov poll was commissioned by a London-based clinical trials startup called Lindus Health, which has a proclaimed mission to “use software to help innovative companies run faster, more reliable, and patient-friendly clinical trials.” “Aside from psilocybin,  those aged between 18-24 were most interested in trialing ketamine…

Read More

[ad_1] The US Open is not played on grass, but there was apparently still plenty of green on Monday as the year’s final tennis grand slam began in New York.  On the women’s side, the eighth-seeded Maria Sakkari lost in an opening round upset to the unseeded Spaniard Rebeka Masarova in straight sets –– a match that the Greek Sakkari let slip away. Leading 4-1 over Masarova in the first set, Sakkari reportedly complained to the chair umpire about a distinct smell that lingered over the court. “It was weed,” Sakkari said after the match, as quoted by the Associated Press.…

Read More